Insiders Updates
EyePoint Pharmaceuticals Inc [EYPT] Investment Appeal on the Rise
EyePoint Pharmaceuticals Inc’s recent filing unveils that its Director Zaderej Karen L. acquired Company’s shares for reported $29950.0 on May
Menu
EyePoint Pharmaceuticals Inc’s recent filing unveils that its Director Zaderej Karen L. acquired Company’s shares for reported $29950.0 on May
EyePoint Pharmaceuticals Inc’s recently made public that its Director Zaderej Karen L. acquired Company’s shares for reported $29950.0 on May
The NASDAQ’s 1.0% gain led the market yesterday, and the S&P 500 and DJIA posted fractional gains. After passing its
The S&P 500 pulled back from its newly acquired all-time high yesterday and 0.4% on the session. The NASDAQ also